Transplantation, AutologousStem Cell TransplantationHematopoietic Stem Cell TransplantationStem CellsMelphalanMultiple MyelomaCombined Modality TherapyPeripheral Blood Stem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsRemission InductionHematopoietic Stem CellsSalvage TherapyTransplantation ConditioningTreatment OutcomeEtoposideInduced Pluripotent Stem CellsThiotepaHodgkin DiseaseHematopoietic Stem Cell MobilizationLymphoma, Non-HodgkinDisease-Free SurvivalBone Marrow PurgingCarmustineCyclophosphamideCytarabinePluripotent Stem CellsVincristineCell DifferentiationTissue EngineeringBlood Transfusion, AutologousEmbryonic Stem CellsRecurrenceAdult Stem CellsAmyloidosisMyeloablative AgonistsCells, CulturedLymphoma, Mantle-CellBone Marrow TransplantationSurvival RateBoronic AcidsPyrazinesDexamethasoneCell- and Tissue-Based TherapyLymphocyte Culture Test, MixedAntigens, CD34Lymphoma, FollicularThalidomideDoxorubicinLymphoma, T-Cell, PeripheralSurvival AnalysisMesenchymal Stem Cell TransplantationRegenerative MedicineAntibodies, Monoclonal, Murine-DerivedAutograftsIfosfamideTransplantation, HomologousWhole-Body IrradiationRegenerationMesenchymal Stromal CellsTissue ScaffoldsRetrospective StudiesCell TransplantationAntineoplastic Agents, AlkylatingStem Cell NicheLeukapheresisPrognosisCell SeparationGranulocyte Colony-Stimulating FactorPodophyllotoxinT-LymphocytesNeural Stem CellsFollow-Up StudiesBusulfanPrednisoneInduction ChemotherapyLymphomaLymphoma, Large B-Cell, DiffuseCytotoxicity, ImmunologicFlow CytometryMultipotent Stem CellsTime FactorsLymphoma, B-CellMaintenance ChemotherapyMitoxantroneCell ProliferationLymphocyte ActivationBone Marrow CellsGraft SurvivalStem Cell FactorT-Lymphocytes, CytotoxicAntineoplastic AgentsClone CellsBlood Component RemovalEnteropathy-Associated T-Cell LymphomaNeoplasm, ResidualHematologic NeoplasmsCarboplatinInfusions, SpinalLeukemia, Plasma CellGenetic Therapy